Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo(5T Torino (Italy)), Dario Sangiolo(Candiolo Cancer Institute)
Cited by 17
Related Papers
Next generation immune-checkpoints for cancer therapy
|Journal of Thoracic Disease|2018|70
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
|British Journal of Cancer|2019|45
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
|Clinical Cancer Research|2020|44